Skip to main content
Acta Crystallographica Section F: Structural Biology and Crystallization Communications logoLink to Acta Crystallographica Section F: Structural Biology and Crystallization Communications
. 2013 Nov 28;69(Pt 12):1322–1327. doi: 10.1107/S174430911302962X

Structure of the secretion domain of HxuA from Haemophilus influenzae

Stéphanie Baelen a, Frédérique Dewitte a, Bernard Clantin a, Vincent Villeret a,*
PMCID: PMC3855712  PMID: 24316822

The structure of the secretion domain of HxuA from H. influenzae has been determined to 1.5 Å resolution.

Keywords: HxuA, TPS, secretion system, β-helix

Abstract

Haemophilus influenzae HxuA is a cell-surface protein with haem–haemopexin binding activity which is key to haem acquisition from haemopexin and thus is one of the potential sources of haem for this microorganism. HxuA is secreted by its specific transporter HxuB. HxuA/HxuB belongs to the so-called two-partner secretion systems (TPSs) that are characterized by a conserved N-­terminal domain in the secreted protein which is essential for secretion. Here, the 1.5 Å resolution structure of the secretion domain of HxuA, HxuA301, is reported. The structure reveals that HxuA301 folds into a β-helix domain with two extra-helical motifs, a four-stranded β-sheet and an N-terminal cap. Comparisons with other structures of TpsA secretion domains are reported. They reveal that despite limited sequence identity, strong structural similarities are found between the β-helix motifs, consistent with the idea that the TPS domain plays a role not only in the interaction with the specific TpsB partners but also as the scaffold initiating progressive folding of the TpsA proteins at the bacterial surface.

1. Introduction  

Haemophilus influenzae has an absolute requirement for haem for aerobic growth. Haem–haemopexin complexes are one of the potential sources of haem for this microorganism. HxuA, a 96.3 kDa cell-surface protein, has haem–haemopexin binding activity and is the key to haem acquisition from haemopexin. HxuA belongs to the HxuCBA system, which consists of an operon encoding three proteins: HxuA, HxuB and the TonB-dependent haem receptor HxuC (Cope et al., 2001). HxuA, which is conserved among H. influenzae strains, is released at the cell surface by its transporter HxuB (Cope et al., 1995), rendering the protein accessible for interaction with haem–haemopexin. Following the interaction between HxuA and haem–haemopexin, haem is released and becomes accessible to the haem receptor HxuC for transport within the bacteria (Fournier et al., 2011).

A key element for efficient HxuA function is thus its transport to the cell surface by its associated transporter HxuB. HxuA/HxuB belongs to the so-called two-partner secretion (TPS) pathway found in Gram-negative bacteria (Jacob-Dubuisson et al., 2009). Currently, hundreds of TPS systems have been identified, mainly from large-scale sequencing initiatives, and an increasing number of them are being characterized. As implied by the name, TPS systems involve pairs of proteins: the secreted proteins are collectively called TpsA proteins (the ‘cargos’) and their outer membrane partners are collectively called TpsB proteins (the ‘transporters’). The defining feature of the TpsA proteins is the presence of a conserved, approximately 250-residue ‘TPS’ domain located at the N-terminus of the mature protein. Most TpsA proteins are large and are predicted to form extended β-helix structures (Kajava et al., 2001; Kajava & Steven, 2006). TpsB partners are 60 kDa proteins that are embedded in the outer membrane and are composed of two large moieties. The periplasmic moiety is formed by two successive POTRA (polypeptide transport-associated) domains (Sánchez-Pulido et al., 2003) involved in the recognition of the TpsA cargo (Hodak et al., 2006; Delattre et al., 2011). The C-terminal moiety is embedded in the outer membrane and forms a 16-stranded antiparallel β-barrel that delimits a channel thought to be the translocation pore for the TpsA partner (Méli et al., 2006). Schematically, the mechanistic model for two-partner secretion is as follows. Like other signal-peptide-dependent secretion pathways, the first step is the export of the TpsA preprotein across the cytoplasmic membrane by the Sec machinery, coupled with signal-peptide cleavage (Braun et al., 1992; Grass & St Geme, 2000; Chevalier et al., 2004). The TpsA protein transits through the periplasm in an extended conformation assisted by chaperones (Baud et al., 2009) and recognizes the periplasmic domain of its cognate TpsB partner, which initiates TpsA translocation through the TpsB pore. The TpsA polypeptide progressively crosses the outer membrane and folds. Additional steps found in a subset of systems include proteolytic maturation of the TpsA protein and/or its release from the cell surface into the milieu (Domenighini et al., 1990; Barenkamp & Leininger, 1992; Ward et al., 1998; Aoki et al., 2005).

Structure-based multiple sequence alignments of the TPS domains of TpsA proteins have revealed two distinct subsets, with FHA, ShlA, LspA, HpmA, HhdA and HecA clustered in one group (Clantin et al., 2004) while HMW1A, HxuA, RscA and EtpA appear to form another more distantly related cluster (Yeo et al., 2007). A similar clustering is revealed for their associated TpsB partners (Jacob-Dubuisson et al., 2009).

Structural studies of FHA/FhaC from Bordetella pertussis led to crystallographic determination of the secretion domain of FHA, Fha30 (Clantin et al., 2004), and its membrane partner FhaC, the only TpsB structure reported to date (Clantin et al., 2007). Further structural data is available on another TpsA: the crystal structure of the secretion domain of Proteus mirabilis HpmA (HpmA265; Weaver et al., 2009) belongs to this subfamily. Only one TpsA structure has been reported for the HMW1A/HMW1B subfamily, the secretion domain of HMW1A (HMW1A-PP; Yeo et al., 2007). The HxuA/HxuB system from H. influenzae belongs to this latter subfamily (Jacob-Dubuisson et al., 2009). To date, all structures reported for TpsA secretion domains originate from proteins which function as adhesins or haemolysins in pathogenic processes, while HxuA has a unique function among TpsA proteins as an interaction protein promoting haem release from haemopexin. Despite these functional differences, HxuA is also predicted to contain an N-terminal domain required for the secretion process, while the functional domains involved in haemopexin recognition are found in the rest of the protein (Cope et al., 1994, 1998; Fournier et al., 2011). As a first attempt to further characterize HxuA at the structural level and gain insights into its secretion process, we produced, purified, crystallized and determined the structure of its secretion domain (HxuA301).

2. Methods  

2.1. Construction of strains, protein expression and purification  

The pFHxuA301 vector was obtained as follows. A 5′ segment of the hxuA gene encoding amino acids 1–301 without the signal peptide was amplified by PCR from H. influenzae Rd KW20 genomic DNA using the forward primer 5′-GCGCAAGCTTCTCGAGAACACCACCACCACCACCACCACCGGGATTTGCCACAAGGTAGCAGTGTAGTT-3′ and the reverse primer 5′-GACAGATCTTTAACCATTGATATTAACGCTTTTGCCTGTAAA-3′. The sequence encoding the histidine tag is shown in bold. The amplicon was purified, digested with XhoI and BglII restriction enzymes (Fermentas) and cloned into the pFLAG-CTS Expression Vector (Sigma–Aldrich), which contains the ompA signal peptide sequence upstream of the multiple cloning site.

The hxuB gene was amplified by PCR from H. influenzae Rd KW20 genomic DNA using the forward primer 5′-CCGCTCGAGAATTAGATCGGCCAGATACTGGA-3′ and the reverse primer 5′-GGA­AGATCTTTAGAAAGTTTTAATCATAGA-3′. The amplicon was purified, digested with XhoI and BglII restriction enzymes (Fermentas) and cloned into the pFLAG-CTS Expression Vector, thus creating pFHxuB. The pCHxuB vector was obtained as follows. The NdeI–BglII fragment encoding the OmpA signal peptide and the HxuB gene was excised from pFHxuB and inserted into the pCOLADuet-1 vector. The integrity of all vectors was verified by DNA sequencing.

The expression vectors pFHxuA301 and pCHxuB were co-transformed into Escherichia coli strain BL21(DE3)omp5 by electroporation (Prilipov et al., 1998). The bacteria were grown at 310 K in 1 l LB medium supplemented with 100 µg ml−1 ampicillin and 25 µg ml−1 kanamycin. Overexpression of His7-HxuA301 and HxuB was induced at an OD600 of 0.6 by the addition of 1 mM isopropyl β-­d-1-thiogalactopyranoside (IPTG) and cell growth was continued for 3 h at 310 K.

After 1 h of centrifugation at 4700g, one tablet of EDTA-free protease-inhibitor cocktail (cOmplete EDTA-free Protease Inhibitor Cocktail, Roche) and 50 mM imidazole pH 6.5 were added to the culture supernatant. The His7-HxuA301 protein contained in the supernatant was purified using a HisTrap FF Crude 1 ml column (GE Healthcare) equilibrated with 50 mM imidazole pH 6.5 and was eluted with 1 M imidazole pH 6.5. After elution, pure His7-HxuA301 was directly recovered at a concentration of 2.8 mg ml−1 (Fig. 1).

Figure 1.

Figure 1

(a) His7-HxuA301 crystal. (b) SDS–PAGE gel of purified His7-HxuA301 (33.3 kDa).

2.2. Crystallization  

Crystallization trials were carried out by the hanging-drop vapour-diffusion method. The conditions from The Cryos Suite screening kit (Qiagen) were investigated by mixing 1 µl protein solution and 1 µl well solution at 293 K. Initial crystallization hits were optimized to obtain suitable crystals for data collection. The best crystallization condition was 1 M imidazole pH 6.5 (from the protein solution), 0.095 M trisodium citrate pH 5.6, 19%(v/v) 2-propanol, 5%(v/v) glycerol, 12%(w/v) PEG 4000 (Fig. 1), yielding crystals that belonged to space group P21 with unit-cell parameters a = 38.99, b = 70.84, c = 104.98 Å, β = 98.1°.

2.3. Data collection and processing  

Prior to data collection, the crystals were briefly soaked in 0.095 M trisodium citrate pH 5.6, 19%(v/v) 2-propanol, 5%(v/v) glycerol, 19%(w/v) PEG 4000. X-ray data were collected at 100 K on the PROXIMA1 beamline at the SOLEIL synchrotron (Gif-sur-Yvette, France). The diffraction data were indexed, integrated, scaled and merged with the XDS package (Kabsch, 2010). The statistics of data collection are summarized in Table 1. The volume of the unit cell suggests the presence of two molecules in the asymmetric unit.

Table 1. Data-collection and refinement statistics for HxuA301 (PDB entry 4i84).

Values in parentheses are for the outermost resolution shell.

Data collection
 Unit-cell parameters (Å, °) a = 38.99, b = 70.84, c = 104.98, β = 98.1
 Space group P21
 Beamline PROXIMA1, SOLEIL
 Wavelength (Å) 0.98011
 Temperature (K) 100
 Detector PILATUS 6M
 Crystal-to-detector distance (mm) 269.63
 Rotation range per image (°) 0.2
 Exposure time per image (s) 0.2
 Images collected 1200
 Resolution (Å) 1.50 (1.59–1.50)
 No. of reflections
  Observed 397746 (62011)
  Unique 89861 (14222)
 Crystal mosaicity (°) 0.2
 Completeness (%) 99.2 (97.8)
 Multiplicity 4.4 (4.4)
R merge(I) (%) 3.6 (27.8)
R meas (%) 4.0 (31.7)
 〈I/σ(I)〉 21.7 (4.6)
Refinement
R work § (%) 15.9 (23.2)
R free (%) 21.0 (29.4)
 Mean B2) 20.9
 No. of non-H atoms
  Protein 4708
  Water 171
 R.m.s.d.
  Bond lengths (Å) 0.027
  Bond angles (°) 2.236
 Ramachandran statistics†† (%)
  Preferred 97.5
  Allowed 2.5
  Disallowed 0.0

R merge = Inline graphic Inline graphic, where I i(hkl) is the observed intensity and 〈I(hkl)〉 is the average intensity for multiple measurements.

R meas = Inline graphic Inline graphic, where N(hkl) is the number of times a given reflection has been observed.

§

R work = Inline graphic Inline graphic, where F obs is the observed structure factor and F calc is the calculated structure factor.

R free is the same as R work, except calculated using 5% of the data that were not included in any refinement calculations.

††

Ramachandran values are given by the PROCHECK software from the CCP4 suite v.6.1.13 (Winn et al., 2011).

2.4. Structure solution and refinement  

The structure of the secretion domain HxuA301 was solved by molecular replacement using MOLREP v.9.2 from the CCP4 suite v.6.1.13 (Winn et al., 2011). A search model based on the HMW1A-PP structure (PDB entry 2odl; Yeo et al., 2007), which shares 26.9% sequence identity with HxuA301, was prepared in which side chains were truncated to alanine using PDBSET from the CCP4 suite v.6.1.13 (Winn et al., 2011). Model building was performed using ARP/wARP v.7.1 (Langer et al., 2008) coupled to the CCP4 package, specifically using REFMAC5 (Murshudov et al., 2011). The two molecules in the asymmetric unit were treated independently during refinement. Rounds of model manipulation using Coot (Emsley et al., 2010) interspersed with refinement using REFMAC5 were used to complete the protein model with the addition of water molecules. The final refinement statistics are presented in Table 1.

The loops between strands β15 and β16 in monomers A and B (see Fig. 4b for β-strand numbering) are not well defined, with residues Leu126–Gln130 and Lys127–Glu134 missing in the electron-density map, respectively. Monomer B presents four additional poorly defined regions (residues Glu113–Asn118, Thr181–Ser185, Glu192–Ala195 and Gly217–Gln220). The overall B factors are 19.2 Å2 for monomer A and 22.6 Å2 for monomer B.

3. Results and discussion  

3.1. General comments and overall structure  

The HxuA301 protein folds as a right-handed parallel β-helix consisting of ten coils (Fig. 2 a). Each coil contributes to a complete turn of the parallel β-helix (Jenkins & Pickersgill, 2001). Like the TPS domains of FHA from B. pertussis and HpmA from P. mirabilis, HxuA301 crystallizes as a homodimeric β-helix (Fig. 2 b). This dimeric organization appears to be functionally irrelevant because it results from the antiparallel β-complementation of the C-­terminal last β-­strands of the truncated protein. The dimensions of a monomer of HxuA301 are 50 × 38 × 30 Å.

Figure 2.

Figure 2

(a) Ribbon representations of the β-helix structure of HxuA301. β1 and β2 are coloured purple, PB1 green, PB2 sky blue, PB3 dark blue and the extra-helical motif β14/β15–β22/β23 pink. (b) Ribbon representation of the HxuA301 dimer corresponding to the asymmetric unit of the crystal. N- and C-terminal extremities are indicated.

The structural motif of the right-handed parallel β-helix is made up of three parallel β-sheets named PB1, PB2 and PB3 (Fig. 2 a). The coils of the β-helix become more regular from the N-terminal to the C-terminal part to finally display a triangular-shaped section. In most right-handed β-helices the hydrophobic core is shielded from the solvent by an amphipathic α-helix at the N-terminus (Jenkins & Pickersgill, 2001). However, the N-terminal capping of the HxuA301 β-helix is carried out not by an α-helix but by strands β1 and β2. β1 and β2 initiate PB2 and PB1, respectively, and represent the only antiparallel strands found in the three parallel β-sheets PB1–3.

Residues whose side chains are oriented towards the interior of the β-helix are mostly hydrophobic. In its β-helix motif, HxuA301 includes ‘stacked’ residues, defined as similar residues found at equivalent position in adjacent coils (Yoder et al., 1993; Petersen et al., 1997; Jenkins & Pickersgill, 2001). The PB1 β-sheet of HxuA301 includes two aliphatic stacks composed of six and ten residues, with the longer stack running along the entire parallel β-sheet. These stacks are composed of alanine, valine, leucine, isoleucine and methionine residues. The PB2 β-sheet of HxuA301 also includes two aliphatic stacks of six and nine residues composed of alanine, valine, leucine and isoleucine residues. Finally, PB3 includes two aliphatic stacks composed of three and eight residues comprising only valine and isoleucine. The shortest aliphatic stack is directly followed by an asparagine ladder involving residues Asn139, Asn158, Asn202 and Asn228 from β16, β19, β24 and β27, respectively. This asparagine ladder is also found in the structure of HMW1A-PP (Yeo et al., 2007). Sequence analyses reveal that this asparagine motif is present in all functionally characterized TpsA proteins of this subfamily, such as the adhesin EtpA from E. coli and RscA from Yersinia enterocolitica, suggesting that this motif might be a signature of the HMW1A subfamily.

HxuA301 presents one extra β-helix motif corresponding to an antiparallel β-sheet composed of strands β14, β15, β22 and β23 and flanked against PB2 (Fig. 2 a). This extra-helical motif interacts with PB2 via one salt bridge (between Arg61 from β7 and Asp107 from β14) and via a network of aromatic–aromatic interactions involving eight residues: three tyrosines (Tyr59, Tyr81 and Tyr171) and five phenylalanines (Phe102, Phe122, Phe148, Phe178 and Phe180) (Fig. 3). Within the HWM1A subfamily, such an extended aromatic–aromatic network is only found in HxuA. The structure of HMW1A-PP reveals a smaller aromatic network involving four residues at the interface between the extra-helical motif and PB2.

Figure 3.

Figure 3

Close-up view of the interaction between the extra-helical motif and PB2. This motif, composed of strands β14, β15, β22 and β23, interacts with PB2 via one salt bridge (between Arg61 from β7 and Asp107 from β14) and via a network of aromatic–aromatic interactions involving eight residues: three tyrosines (Tyr59, Tyr81 and Tyr171) and five phenylalanines (Phe102, Phe122, Phe148, Phe178 and Phe180).

3.2. Structure comparison  

HxuA301 from H. influenzae is the fourth TpsA secretion-domain structure to be reported to date, in addition to those of Fha30 from B. pertussis (PDB entry 1rwr; Clantin et al., 2004), HMW1A-PP from H. influenzae (PDB entry 2odl; Yeo et al., 2007) and HpmA265 from P. mirabilis (PDB entry 3fy3; Weaver et al., 2009). All secretion domains form a right-handed β-helix structure composed of three parallel β-sheets and capped by two or three β-strands (Fig. 4). This capping is specific to TpsA proteins; in other proteins adopting a right-handed β-helical fold, the hydrophobic core is shielded from the solvent by an amphipathic α-helix at the N-terminus. This specificity may result from the specialization of TPS systems for the secretion of proteins essentially composed of amphipathic β-strands.

Figure 4.

Figure 4

Structural alignment of TPS domains from TpsAs of known structure. β1 and β2 are coloured purple, PB1 green, PB2 sky blue, PB3 dark blue and the extra-helical motifs pink (and yellow in the case of the α-helix present in the HMW1A structure). The loop β7*/β8* specific to the FHA/FhaC subfamily is coloured red. (a) Ribbon representation of the structural alignment of TPS domains from HxuA301, HMW1A (PDB entry 2odl), HpmA (PDB entry 3fy3) and FHA (PDB entry 1rwr). (b) Sequence alignment based on structural alignment of TPS domains of known structure. The residues whose side chains are oriented towards the interior of the β-helix are marked by a black triangle.

Despite the low sequence conservation, the extra-helical motif β14/β15–β22/β23 forming an antiparallel β-sheet is systematically observed, with a slight difference in HMW1A-PP, in which strand β14 is replaced by an α-helix (represented in yellow in Fig. 4). The functional role of this α-helix is still unknown. The conserved extra-helical motif may presumably be required at some stage in the mechanism of secretion. Indeed, functional studies of the FHA/FhaC system revealed that the deletion of hairpins in this region drastically reduced secretion (Hodak et al., 2006).

The TpsA proteins are divided into two subfamilies: the FHA and the HMW1A subfamilies (Yeo et al., 2007; Jacob-Dubuisson et al., 2009). In addition to the β14/β15–β22/β23 motif, TpsA proteins from the FHA subfamily show a second extra-helical motif made up by a long extension containing two antiparallel β-­strands, designated loop β7*/β8*. This extension includes the NPNL motif which is conserved throughout this subfamily. Although of unknown function, this motif may play a specific role in the secretion mechanism of these TpsA proteins, for which a stable interaction between the N-terminal extremity of FHA and FhaC has been hypothesized during the secretion process (Mazar & Cotter, 2006).

HMW1A-PP, Fha30 and HpmA265 share 30.3, 14 and 14% identity, respectively, with HxuA over the 301 residues of the HxuA construct. The r.m.s. deviation calculated from residues whose side chains are oriented towards the interior of the helix (marked by a black triangle in Fig. 4 b) is 0.55 Å between HxuA301 and HMW1A-PP, 1.41 Å between HxuA301 and HpmA265 and 1.29 Å between HxuA301 and FHA30. Thus, despite limited sequence identity, strong structural similarities are found between the β-helix motifs of TpsA proteins.

Supplementary Material

PDB reference: secretion domain of HxuA, 4i84

Acknowledgments

We thank the PROXIMA1 beamline staff for support during data collection. SB is supported by a PhD fellowship from the CNRS. FD, BC and VV are researchers from the CNRS. This work has been supported by the CNRS, ANR grant DYN FHAC (2010–2014), the Region Nord-Pas-de-Calais (France) and the CPER–CIA.

References

  1. Aoki, S. K., Pamma, R., Hernday, A. D., Bickham, J. E., Braaten, B. A. & Low, D. A. (2005). Science, 309, 1245–1248. [DOI] [PubMed]
  2. Barenkamp, S. J. & Leininger, E. (1992). Infect. Immun. 60, 1302–1313. [DOI] [PMC free article] [PubMed]
  3. Baud, C., Hodak, H., Willery, E., Drobecq, H., Locht, C., Jamin, M. & Jacob-Dubuisson, F. (2009). Mol. Microbiol. 74, 315–329. [DOI] [PubMed]
  4. Braun, V., Hobbie, S. & Ondraczek, R. (1992). FEMS Microbiol. Lett. 79, 299–305. [DOI] [PubMed]
  5. Chevalier, N., Moser, M., Koch, H.-G., Schimz, K.-L., Willery, E., Locht, C., Jacob-Dubuisson, F. & Müller, M. (2004). J. Mol. Microbiol. Biotechnol. 8, 7–18. [DOI] [PubMed]
  6. Clantin, B., Delattre, A.-S., Rucktooa, P., Saint, N., Méli, A. C., Locht, C., Jacob-Dubuisson, F. & Villeret, V. (2007). Science, 317, 957–961. [DOI] [PubMed]
  7. Clantin, B., Hodak, H., Willery, E., Locht, C., Jacob-Dubuisson, F. & Villeret, V. (2004). Proc. Natl. Acad. Sci. USA, 101, 6194–6199. [DOI] [PMC free article] [PubMed]
  8. Cope, L. D., Love, R. P., Guinn, S. E., Gilep, A., Usanov, S., Estabrook, R. W., Hrkal, Z. & Hansen, E. J. (2001). Infect. Immun. 69, 2353–2363. [DOI] [PMC free article] [PubMed]
  9. Cope, L. D., Thomas, S. E., Hrkal, Z. & Hansen, E. J. (1998). Infect. Immun. 66, 4511–4516. [DOI] [PMC free article] [PubMed]
  10. Cope, L. D., Thomas, S. E., Latimer, J. L., Slaughter, C. A., Müller-Eberhard, U. & Hansen, E. J. (1994). Mol. Microbiol. 13, 863–873. [DOI] [PubMed]
  11. Cope, L. D., Yogev, R., Muller-Eberhard, U. & Hansen, E. J. (1995). J. Bacteriol. 177, 2644–2653. [DOI] [PMC free article] [PubMed]
  12. Delattre, A.-S., Saint, N., Clantin, B., Willery, E., Lippens, G., Locht, C., Villeret, V. & Jacob-Dubuisson, F. (2011). Mol. Microbiol. 81, 99–112. [DOI] [PubMed]
  13. Domenighini, M., Relman, D., Capiau, C., Falkow, S., Prugnola, A., Scarlato, V. & Rappuoli, R. (1990). Mol. Microbiol. 4, 787–800. [DOI] [PubMed]
  14. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. (2010). Acta Cryst. D66, 486–501. [DOI] [PMC free article] [PubMed]
  15. Fournier, C., Smith, A. & Delepelaire, P. (2011). Mol. Microbiol. 80, 133–148. [DOI] [PubMed]
  16. Grass, S. & St Geme, J. W. III (2000). Mol. Microbiol. 36, 55–67. [DOI] [PubMed]
  17. Hodak, H., Clantin, B., Willery, E., Villeret, V., Locht, C. & Jacob-Dubuisson, F. (2006). Mol. Microbiol. 61, 368–382. [DOI] [PubMed]
  18. Jacob-Dubuisson, F., Villeret, V., Clantin, B., Delattre, A.-S. & Saint, N. (2009). Biol. Chem. 390, 675–684. [DOI] [PubMed]
  19. Jenkins, J. & Pickersgill, R. (2001). Prog. Biophys. Mol. Biol. 77, 111–175. [DOI] [PubMed]
  20. Kabsch, W. (2010). Acta Cryst. D66, 125–132. [DOI] [PMC free article] [PubMed]
  21. Kajava, A. V., Cheng, N., Cleaver, R., Kessel, M., Simon, M. N., Willery, E., Jacob-Dubuisson, F., Locht, C. & Steven, A. C. (2001). Mol. Microbiol. 42, 279–292. [DOI] [PubMed]
  22. Kajava, A. V. & Steven, A. C. (2006). Adv. Protein Chem. 73, 55–96. [DOI] [PubMed]
  23. Langer, G., Cohen, S. X., Lamzin, V. S. & Perrakis, A. (2008). Nature Protoc. 3, 1171–1179. [DOI] [PMC free article] [PubMed]
  24. Mazar, J. & Cotter, P. A. (2006). Mol. Microbiol. 62, 641–654. [DOI] [PubMed]
  25. Méli, A. C., Hodak, H., Clantin, B., Locht, C., Molle, G., Jacob-Dubuisson, F. & Saint, N. (2006). J. Biol. Chem. 281, 158–166. [DOI] [PubMed]
  26. Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F. & Vagin, A. A. (2011). Acta Cryst. D67, 355–367. [DOI] [PMC free article] [PubMed]
  27. Petersen, T. N., Kauppinen, S. & Larsen, S. (1997). Structure, 5, 533–544. [DOI] [PubMed]
  28. Prilipov, A., Phale, P. S., Van Gelder, P., Rosenbusch, J. P. & Koebnik, R. (1998). FEMS Microbiol. Lett. 163, 65–72. [DOI] [PubMed]
  29. Sánchez-Pulido, L., Devos, D., Genevrois, S., Vicente, M. & Valencia, A. (2003). Trends Biochem. Sci. 28, 523–526. [DOI] [PubMed]
  30. Ward, C. K., Lumbley, S. R., Latimer, J. L., Cope, L. D. & Hansen, E. J. (1998). J. Bacteriol. 180, 6013–6022. [DOI] [PMC free article] [PubMed]
  31. Weaver, T. M., Hocking, J. M., Bailey, L. J., Wawrzyn, G. T., Howard, D. R., Sikkink, L. A., Ramirez-Alvarado, M. & Thompson, J. R. (2009). J. Biol. Chem. 284, 22297–22309. [DOI] [PMC free article] [PubMed]
  32. Winn, M. D. et al. (2011). Acta Cryst. D67, 235–242.
  33. Yeo, H.-J., Yokoyama, T., Walkiewicz, K., Kim, Y., Grass, S. & St Geme, J. W. III (2007). J. Biol. Chem. 282, 31076–31084. [DOI] [PubMed]
  34. Yoder, M. D., Lietzke, S. E. & Jurnak, F. (1993). Structure, 1, 241–251. [DOI] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

PDB reference: secretion domain of HxuA, 4i84


Articles from Acta Crystallographica Section F: Structural Biology and Crystallization Communications are provided here courtesy of International Union of Crystallography

RESOURCES